Evaluation of the "Intranasal Fentanyl" Protocol in Pediatric Surgical Emergencies at Strasbourg University Hospital

Sponsor
University Hospital, Strasbourg, France
Study ID
NCT06832046
Status
Recruiting
Apply to this trial

Conditions

  • Musculoskeletal Pain

Eligibility Criteria

Sex
ALL
Age
1 Year - 17 Years
Healthy Volunteers
Not accepted

Study Details

Emergency trauma departments receive thousands of patients each year whose main symptom is pain. In recent years, intranasal fentanyl (FIN) has entered the therapeutic arsenal to treat pain in the emergency department. Various studies have validated its effectiveness for musculoskeletal pain as well as its tolerance and safety of use. Since then, new protocols have been implemented including this treatment. In This study, the investigators propose to retrospectively study the quality of prescription of intranasal fentanyl in the treatment of pain in the emergency department and the quality of monitoring of this treatment in current practice.

Key Dates

First listed
Feb 18, 2025
Start date
Oct 28, 2024
Status verified
Feb 2025
Primary completion
Apr 30, 2026
Completion
Apr 28, 2026

Study Design

Enrollment
500 participants (estimated)

Primary Outcome Measure

The judgment criterion is composite in order to retrospectively evaluate the relevance of the prescription, administration and monitoring of the intranasal fentanyl (FIN) protocol. [ Time Frame: Up to 2 years ]

Central Contacts

Related Studies